Impact of the publication of the Finnish Meds75+ database on the use of potentially inappropriate medications in older persons

Author:

Hyttinen Virva1ORCID,Kortelainen Lauri1,Rantsi Mervi1ORCID,Jyrkkä Johanna2ORCID,Linnosmaa Ismo13ORCID

Affiliation:

1. Department of Health and Social Management University of Eastern Finland Kuopio Finland

2. Information and Development Services Unit Finnish Medicines Agency Kuopio Finland

3. Welfare State Research and Reform National Institute for Health and Welfare Helsinki Finland

Abstract

AbstractAimsTo evaluate the impact of the updated nationwide Meds75+ database and its linkage to the Finnish health portal on the use of potentially inappropriate medications (PIMs) among older persons. We also aimed to evaluate whether there is regional variation in trend changes of PIM use.MethodsMeds75+ was implemented at the population level in 2015, so randomization is unfeasible. We used a quasi‐experimental interrupted time series analysis to evaluate the changes in levels and trends of PIM use. The data included all Finnish community‐dwelling persons aged ≥75 years (N = 920 163) who had medication purchases in the Prescription Register during 2009‐2020. Data were linked with the Care Registers for Health and Social Care and the cause of death register.ResultsThe prevalence of PIMs decreased from 20.2% in 2009 to 11.7% in 2020. The change of level of the monthly PIM users was negative (β −0.036, 95% confidence interval [CI] −0.202 to 0.131), but not statistically significant (P = .673) after the publication of the database. We found a small decrease (β −0.018, 95% CI −0.083 to 0.047, P = .593) in the slope of PIM users, but it was not statistically significant. The regional results were similar to the main findings.ConclusionsPublication of the updated Meds75+ database did not decrease the level or trend of PIM users. In addition, this study did not show any significant regional variation in PIM use trends. Further research should focus on determining barriers and facilitators to the utilization of PIM criteria in clinical practice.

Funder

Kela

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3